Although in our previous study we found that the HOXB13 p.R217C mutation was 3.5-fold more prevalent in cases than controls, the association between p.R217C and breast cancer risk was not statistically significant and the estimation of the risk was not very precise. Here, HOXB13 is linked to breast cancer.